Evidence map›Paper›PMID 40257942›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2025

Primaquine-induced methemoglobinemia in a child treated for malaria

Sara Puerta, Hardenson Rodríguez

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara PuertaEspecialización en Pediatría, Universidad Pontificia Bolivariana, Medellín, Colombia.ORCID 0009-0009-3269-9542
Hardenson RodríguezServicio de Pediatría, Hospital Pablo Tobón Uribe, Medellín, Colombia; Especialización en Oncohematología Pediátrica, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID 0000-0001-7027-7476

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methemoglobinemia results from an increased concentration of methemoglobin in the blood, impairing oxygen delivery to tissues. It is considered a rare condition that requires a high diagnostic suspicion. We report the case of a pediatric patient with malaria who presented with cyanosis and hypoxemia as manifestations of methemoglobinemia induced by primaquine treatment. The patient responded adequately after antimalarial drug suspension and ascorbic acid administration.

Indexed as

AntimalarialsMalariaMalaria, FalciparumMethemoglobinemiaPrimaquineAscorbic AcidChildCyanosisHumansHypoxiaMaleAntimalarialsAscorbic AcidPrimaquinecianosismalariamethemoglobinmethemoglobinemiapediatricsprimaquine

Identifiers

PMID40257942
PMCPMC12097778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.